Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion

Human T lymphotropic virus-1 (HTLV-1) was the first identified oncoretrovirus, which infects and establishes a persistent infection in approximately 10–20 million people worldwide. Although only ~5% of infected individuals develop pathologies such as adult T-cell leukemia/lymphoma (ATLL) or a neuroi...

Full description

Bibliographic Details
Main Authors: Suchitra Mohanty, Edward W. Harhaj
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/12/5/735
_version_ 1797598758021627904
author Suchitra Mohanty
Edward W. Harhaj
author_facet Suchitra Mohanty
Edward W. Harhaj
author_sort Suchitra Mohanty
collection DOAJ
description Human T lymphotropic virus-1 (HTLV-1) was the first identified oncoretrovirus, which infects and establishes a persistent infection in approximately 10–20 million people worldwide. Although only ~5% of infected individuals develop pathologies such as adult T-cell leukemia/lymphoma (ATLL) or a neuroinflammatory disorder termed HTLV-1-asssociated myelopathy/tropical spastic paraparesis (HAM/TSP), asymptomatic carriers are more susceptible to opportunistic infections. Furthermore, ATLL patients are severely immunosuppressed and prone to other malignancies and other infections. The HTLV-1 replication cycle provides ligands, mainly nucleic acids (RNA, RNA/DNA intermediates, ssDNA intermediates, and dsDNA), that are sensed by different pattern recognition receptors (PRRs) to trigger immune responses. However, the mechanisms of innate immune detection and immune responses to HTLV-1 infection are not well understood. In this review, we highlight the functional roles of different immune sensors in recognizing HTLV-1 infection in multiple cell types and the antiviral roles of host restriction factors in limiting persistent infection of HTLV-1. We also provide a comprehensive overview of intricate strategies employed by HTLV-1 to subvert the host innate immune response that may contribute to the development of HTLV-1-associated diseases. A more detailed understanding of HTLV-1-host pathogen interactions may inform novel strategies for HTLV-1 antivirals, vaccines, and treatments for ATLL or HAM/TSP.
first_indexed 2024-03-11T03:25:16Z
format Article
id doaj.art-39cd4ae4b0084c2a9d81ed0563228a89
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-11T03:25:16Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-39cd4ae4b0084c2a9d81ed0563228a892023-11-18T02:47:37ZengMDPI AGPathogens2076-08172023-05-0112573510.3390/pathogens12050735Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune EvasionSuchitra Mohanty0Edward W. Harhaj1Department of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA 17033, USADepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA 17033, USAHuman T lymphotropic virus-1 (HTLV-1) was the first identified oncoretrovirus, which infects and establishes a persistent infection in approximately 10–20 million people worldwide. Although only ~5% of infected individuals develop pathologies such as adult T-cell leukemia/lymphoma (ATLL) or a neuroinflammatory disorder termed HTLV-1-asssociated myelopathy/tropical spastic paraparesis (HAM/TSP), asymptomatic carriers are more susceptible to opportunistic infections. Furthermore, ATLL patients are severely immunosuppressed and prone to other malignancies and other infections. The HTLV-1 replication cycle provides ligands, mainly nucleic acids (RNA, RNA/DNA intermediates, ssDNA intermediates, and dsDNA), that are sensed by different pattern recognition receptors (PRRs) to trigger immune responses. However, the mechanisms of innate immune detection and immune responses to HTLV-1 infection are not well understood. In this review, we highlight the functional roles of different immune sensors in recognizing HTLV-1 infection in multiple cell types and the antiviral roles of host restriction factors in limiting persistent infection of HTLV-1. We also provide a comprehensive overview of intricate strategies employed by HTLV-1 to subvert the host innate immune response that may contribute to the development of HTLV-1-associated diseases. A more detailed understanding of HTLV-1-host pathogen interactions may inform novel strategies for HTLV-1 antivirals, vaccines, and treatments for ATLL or HAM/TSP.https://www.mdpi.com/2076-0817/12/5/735HTLV-1ATLLimmune sensorsrestriction factorsimmune evasionTax
spellingShingle Suchitra Mohanty
Edward W. Harhaj
Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
Pathogens
HTLV-1
ATLL
immune sensors
restriction factors
immune evasion
Tax
title Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
title_full Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
title_fullStr Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
title_full_unstemmed Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
title_short Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
title_sort mechanisms of innate immune sensing of htlv 1 and viral immune evasion
topic HTLV-1
ATLL
immune sensors
restriction factors
immune evasion
Tax
url https://www.mdpi.com/2076-0817/12/5/735
work_keys_str_mv AT suchitramohanty mechanismsofinnateimmunesensingofhtlv1andviralimmuneevasion
AT edwardwharhaj mechanismsofinnateimmunesensingofhtlv1andviralimmuneevasion